# Micronized dHACM Injectable for the Treatment of Plantar Fasciitis

> **NCT02427191** · PHASE2,PHASE3 · COMPLETED · sponsor: **MiMedx Group, Inc.** · enrollment: 147 (actual)

## Conditions studied

- Fasciitis, Plantar

## Interventions

- **OTHER:** AmnioFix® Injectable
- **DRUG:** Saline Injection

## Key facts

- **NCT ID:** NCT02427191
- **Lead sponsor:** MiMedx Group, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-31
- **Primary completion:** 2018-08
- **Final completion:** 2018-08
- **Target enrollment:** 147 (ACTUAL)
- **Last updated:** 2020-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02427191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02427191, "Micronized dHACM Injectable for the Treatment of Plantar Fasciitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02427191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*